| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Centre for Functional Magnetic Resonance Imaging of the Brain (C.W., P.M.M.) and Departments of Neuropathology (C.W., M.M.E.), Psychiatry (S.A.C.), and Clinical Neurology (C.W., M.M.E., S.A.C., J.P., P.M.M.), University of Oxford, UK.
Address correspondence and reprint requests to Dr. C. Wegner, FMRIB Centre, John Radcliffe Hospital, Headley Way, Headington, Oxford, UK OX3 9DU; e-mail: chrwegner{at}gmx.de
Background: Recent pathologic investigations have shown that neocortical lesions are frequent in multiple sclerosis (MS). Structural MRI has shown that neocortical atrophy occurs early and can be substantial, but the specific substrate for this atrophy has not been defined quantitatively.
Objective: To investigate cortical thickness as well as neuronal, glial, and synaptic densities in MS.
Methods: We studied brain samples from 22 patients with MS and 17 control subjects. Neocortical lesions and cortical thickness were assessed on sections stained for myelin basic protein. Neuronal, glial, and synaptic densities were measured in type I leukocortical lesions, nonlesional neocortex, and non-MS control cortex. Immunoautoradiography was used to quantify synaptic densities.
Results: Neocortical lesions were common in patients with MS. Subpial type III (44%) and leukocortical type I (38%) lesions were more abundant than intracortical type II (18%) lesions. An overall relative neocortical thinning of 10% (p = 0.016) was estimated for the patients. Within the type I lesions, we found evidence for substantial cell (glial, 36%, p = 0.001; neuronal, 10%, p = 0.032) and synaptic (47% decrease in synaptophysin, p = 0.001) loss. Nonlesional neocortex did not show significant relative changes in neuronal, glial, or synaptic density.
Conclusions: Neocortical neuronal and glial degeneration is significant in multiple sclerosis. Synaptic loss was particularly striking in the neocortical lesions, which should make a major independent contribution to the expression of pathology. New therapies should be directed toward limiting this damage.
Supported by the European Commission (C.W.), the Multiple Sclerosis Society of Great Britain and Northern Ireland (M.M.E., P.M.M.), and the Medical Research Council (P.M.M.).
Disclosure: The authors report no conflicts of interest.
Received September 7, 2005. Accepted in final form May 12, 2006.
This article has been cited by other articles:
|
|
 |
|
  J. M. Frischer, S. Bramow, A. Dal-Bianco, C. F. Lucchinetti, H. Rauschka, M. Schmidbauer, H. Laursen, P. S. Sorensen, and H. Lassmann The relation between inflammation and neurodegeneration in multiple sclerosis brains Brain, May 1, 2009; 132(5): 1175 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kollia, S. Maderwald, N. Putzki, M. Schlamann, J.M. Theysohn, O. Kraff, M.E. Ladd, M. Forsting, and I. Wanke First Clinical Study on Ultra-High-Field MR Imaging in Patients with Multiple Sclerosis: Comparison of 1.5T and 7T AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 699 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Nelson, A Poonawalla, P Hou, J. Wolinsky, and P. Narayana 3D MPRAGE improves classification of cortical lesions in multiple sclerosis Multiple Sclerosis, November 1, 2008; 14(9): 1214 - 1219. [Abstract] [PDF]
|
|
|
|
|
|
J Toledo, J Sepulcre, A Salinas-Alaman, A Garcia-Layana, M Murie-Fernandez, B Bejarano, and P Villoslada Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis Multiple Sclerosis, August 1, 2008; 14(7): 906 - 912. [Abstract] [PDF]
|
|
|
|
|
|
J. M. Anderson, D. W. Hampton, R. Patani, G. Pryce, R. A. Crowther, R. Reynolds, R. J. M. Franklin, G. Giovannoni, D. A. S. Compston, D. Baker, et al. Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis Brain, July 1, 2008; 131(7): 1736 - 1748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Sicotte, K. C. Kern, B. S. Giesser, A. Arshanapalli, A. Schultz, M. Montag, H. Wang, and S. Y. Bookheimer Regional hippocampal atrophy in multiple sclerosis Brain, April 1, 2008; 131(4): 1134 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Poonawalla, K. M. Hasan, R. K. Gupta, C. W. Ahn, F. Nelson, J. S. Wolinsky, and P. A. Narayana Diffusion-Tensor MR Imaging of Cortical Lesions in Multiple Sclerosis: Initial Findings Radiology, March 1, 2008; 246(3): 880 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rasmussen, Y. Wang, P. Kivisakk, R. T. Bronson, M. Meyer, J. Imitola, and S. J. Khoury Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing remitting experimental autoimmune encephalomyelitis Brain, November 1, 2007; 130(11): 2816 - 2829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Calabrese, N. De Stefano, M. Atzori, V. Bernardi, I. Mattisi, L. Barachino, A. Morra, L. Rinaldi, C. Romualdi, P. Perini, et al. Detection of Cortical Inflammatory Lesions by Double Inversion Recovery Magnetic Resonance Imaging in Patients With Multiple Sclerosis Arch Neurol, October 1, 2007; 64(10): 1416 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zivadinov Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis? Neurology, May 29, 2007; 68(22_suppl_3): S72 - S82. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
